Clinical Trial

Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement

Recruiting
View on ClinicalTrials.gov →
Summary
Transcatheter tricuspid valve replacement (TTVR) is associated with a high risk of third-degree atrioventricular block (AVB). However, the optimal pacemaker management following TTVR remains unclear. This study aims to identify an optimal therapeutic approach for pacemaker implantation in patients undergoing TTVR.
Trial Details
NCT Number NCT06814574
Lead Sponsor Deutsches Herzzentrum Muenchen
Conditions AV Block Complete, Tricuspid Regurgitation (TR)
Enrollment 25 participants
Start Date 2024-01-01
Primary Completion 2025-01-31 (estimated)
Study Completion 2025-01-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-07